Mr. Thierry Dumas reports

OPSENS RECEIVES ORDERS WORTH $1.2 MILLION FOR ITS FFR PRODUCTS FROM JAPAN

Opsens Inc. has received orders worth over $1.2-million for its products to measure fractional flow reserve (FFR) from the Japanese market. Opsens's FFR products are designed to optimize the diagnostic and guide treatment in patients with coronary heart disease.

The orders placed by Opsens's Japanese distributor, a player in interventional cardiology at the head of a well-organized distribution network, more than double Opsens's FFR revenues from fiscal year 2015.

"The receipt of these orders, during the limited market release phase for the single territory of Japan is a very good sign," said Louis Laflamme, president and chief executive officer of Opsens. "In parallel to the progress in Japan, Opsens is also working to expand its commercial activities in several other geographical territories, which will generate strong growth for Opsens's FFR revenue in fiscal 2016."

We seek Safe Harbor.